Susquehanna International Group, LLP Geron Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $157,626 - $188,622	37,800 Added 4.66%	848,600 $3.85 Million
Q2 2024 Aug 15, 2024	BUY	$3.1 - $5.09 $103,230 - $169,497	33,300 Added 4.28%	810,800 $3.44 Million
Q1 2024 May 07, 2024	BUY	$1.75 - $3.44 $1.15 Million - $2.27 Million	659,000 Added 556.12%	777,500 $2.57 Million
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $456,054 - $605,451	-262,100 Reduced 68.86%	118,500 $250,000
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $224,082 - $348,336	-106,200 Reduced 21.82%	380,600 $806,000
Q2 2023 Aug 11, 2023	SELL	$1.97 - $3.69 $80,179 - $150,183	-40,700 Reduced 7.72%	486,800 $1.56 Million
Q1 2023 May 16, 2023	SELL	$2.14 - $3.4 $1.43 Million - $2.28 Million	-669,600 Reduced 55.94%	527,500 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $40,599 - $48,400	-20,000 Reduced 1.64%	1,197,100 $2.9 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $475,616 - $837,312	284,800 Added 30.55%	1,217,100 $2.85 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $80,801 - $112,035	67,900 Added 7.86%	932,300 $1.45 Million
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $69,894 - $112,960	-70,600 Reduced 7.55%	864,400 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $360,022 - $507,572	-295,100 Reduced 23.99%	935,000 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $188,040 - $235,050	156,700 Added 14.6%	1,230,100 $1.69 Million
Q2 2021 Aug 11, 2021	BUY	$1.25 - $1.83 $100,500 - $147,132	80,400 Added 8.1%	1,073,400 $1.51 Million
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $765,320 - $1.06 Million	503,500 Added 102.86%	993,000 $1.57 Million
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $257,455 - $340,504	166,100 Added 51.36%	489,500 $778,000
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $34,821 - $47,961	21,900 Added 7.26%	323,400 $563,000
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $255,045 - $529,522	242,900 Added 414.51%	301,500 $657,000
Q1 2020 May 15, 2020	SELL	$0.89 - $1.49 $147,829 - $247,489	-166,100 Reduced 73.92%	58,600 $70,000
Q4 2019 Feb 14, 2020	BUY	$1.27 - $1.54 $35,687 - $43,274	28,100 Added 14.29%	224,700 $306,000
Q3 2019 Nov 14, 2019	SELL	$1.15 - $1.59 $122,244 - $169,017	-106,300 Reduced 35.09%	196,600 $261,000
Q2 2019 Aug 14, 2019	SELL	$1.37 - $2.02 $168,099 - $247,854	-122,700 Reduced 28.83%	302,900 $427,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $40,703 - $73,749	-40,300 Reduced 8.65%	425,600 $706,000
Q4 2018 Feb 14, 2019	SELL	$0.98 - $1.85 $34,594 - $65,305	-35,300 Reduced 7.04%	465,900 $466,000
Q3 2018 Nov 14, 2018	SELL	$1.76 - $6.38 $76,560 - $277,530	-43,500 Reduced 7.99%	501,200 $882,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $2,961 - $4,338	900 Added 0.17%	544,700 $1.87 Million
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $916,584 - $3.03 Million	506,400 Added 1354.01%	543,800 $2.31 Million
Q4 2017 Feb 14, 2018	BUY	$1.8 - $2.32 $67,320 - $86,768	37,400	37,400 $67,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account